REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 270.00
Bid: 265.00
Ask: 275.00
Change: 5.00 (1.89%)
Spread: 10.00 (3.774%)
Open: 265.00
High: 270.00
Low: 265.00
Prev. Close: 265.00
ANP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Full Year Trading Statement

9 Jan 2023 07:00

RNS Number : 0159M
Anpario PLC
09 January 2023
 
 Anpario plc("Anpario" or the "Group")

 

Full Year Trading Statement

 

Anpario, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, provides the following trading update for the year ended 31 December 2022.

 

Trading update

The Group experienced a weaker than expected final quarter, and in particular December's performance was adversely affected by several factors including our Chinese subsidiary where customer orders were impacted by the spread of Covid following the relaxation of restrictions. Other factors included orders which left the factory on time but were delayed at the port due to last minute shipping schedule changes and therefore missed the statutory cut-off period and certain other orders waiting for letters of credit and import permits which are now expected in early 2023.

 

During the year the Group experienced significant headwinds including raw material and logistics costs increases which reduced our margins, although margins did improve in the second half. Our customers have also been impacted by cost pressures, notably feed and energy, which is hurting their profitability and, in some cases, viability leading to reduced volumes of our products.

 

As previously announced in our interim report in September, the Group had legal and professional costs in relation to specific acquisition opportunities that did not proceed. For the full-year results, due to the exceptional and non-recurring nature of these costs, they will be excluded from our alternative profit measures such as adjusted EBITDA.

 

As a result of these factors, and subject to audit, we expect full year sales to be at least £33m and adjusted EBITDA1 to be not less than £5m.

 

We expect the global economy to continue to be challenging, however, we are encouraged by the improvement in our gross margins in recent months as a result of our actions to increase sales prices and are experiencing an easing of raw material price inflation, both of which are helping the Group to rebuild its margins. We continue to invest in our global sales teams and product development which will help deliver profitable growth of the Group.

Financial position

Our financial position remains strong with year-end cash balances of £13.6m (30 Jun 2022: £13.3m). Through the second half of the year we increased cash by £0.3m, after £2.2m of dividend payments and further capital investments. Global logistics have been challenging over the past 18 months and in order to ensure supply to our customers we built up contingency in our inventory. However, the situation has started to improve and as such we have been able to start to reduce our working capital requirements and this process will continue into the new year.

 

Final results date

The Group expects to announce its final results for the year ended 31 December 2022 on 22 March 2023.

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Group's obligations under Article 17 of MAR.

 

 

1 Adjusted EBITDA represents operating profit for the year adjusted for: acquisition costs; share based payments and associated costs; and depreciation, amortisation and impairment charges.

 

 

 

Enquiries

 

Anpario plc

 

Richard Edwards, CEO

+44(0)7776 417 129

Marc Wilson, Group Finance Director

+44(0)1909 537 380

 

 

Peel Hunt LLP (NOMAD)

+44(0)20 7418 8900

Adrian Trimmings

 

Andrew Clark

 

Lalit Bose

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPUAAGUPWPUR
Date   Source Headline
4th May 20221:14 pmRNSTotal Voting Rights
28th Apr 202211:17 amRNSHolding(s) in Company
20th Apr 20221:49 pmRNSHolding(s) in Company
19th Apr 20223:47 pmRNSHolding(s) in Company
8th Apr 20227:00 amRNSDirectorate Change
6th Apr 202210:10 amRNSHolding(s) in Company
6th Apr 202210:09 amRNSTotal Voting Rights
1st Apr 20223:41 pmRNSHolding(s) in Company
25th Mar 202210:40 amRNSHolding(s) in Company
24th Mar 202212:57 pmRNSGrant of share awards
22nd Mar 20225:08 pmRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSFinal Results
8th Mar 20222:35 pmRNSBlock listing Interim Review
8th Mar 20222:34 pmRNSTotal Voting Rights
26th Jan 20227:00 amRNSFull Year Trading Statement
3rd Dec 20217:00 amRNSUK patent granted for Orego-stim
18th Nov 20211:17 pmRNSHolding(s) in Company
10th Nov 20217:00 amRNSNew Commitment to Sustainable Operations
3rd Nov 202112:04 pmRNSTotal Voting Rights
1st Nov 202110:03 amRNSHolding(s) in Company
26th Oct 20214:28 pmRNSHolding(s) in Company
12th Oct 20217:20 amRNSDirector/PDMR Shareholding
15th Sep 202111:51 amRNSHalf-year Report - Replacement
15th Sep 20217:00 amRNSHalf-year Report
3rd Aug 20219:52 amRNSTotal Voting Rights
20th Jul 20219:42 amRNSBlock listing Interim Review
9th Jul 20212:16 pmRNSAnpario receives “Community Business Hero Award"
17th Jun 20211:24 pmRNSResult of AGM
17th Jun 20217:00 amRNSAGM Statement
7th Jun 20213:58 pmRNSDirector/PDMR Shareholding
24th May 20219:48 amRNSHolding(s) in Company
18th May 20217:00 amRNSNotice of AGM
4th May 20214:16 pmRNSDirector/PDMR Shareholding
4th May 20214:10 pmRNSTotal Voting Rights
28th Apr 20214:00 pmRNSDirector/PDMR Shareholding
22nd Apr 20214:05 pmRNSDirector/PDMR Shareholding
19th Apr 20217:00 amRNSBoard update
13th Apr 20219:17 amRNSHolding(s) in Company
13th Apr 20219:17 amRNSHolding(s) in Company
6th Apr 20211:50 pmRNSDirector/PDMR Shareholding
30th Mar 20213:39 pmRNSDirector/PDMR Shareholding
17th Mar 20217:01 amRNSDirectorate Change
17th Mar 20217:00 amRNSFinal Results
15th Mar 20213:38 pmRNSDirector/PDMR Shareholding
12th Mar 20217:00 amRNSDirectorate Change
4th Feb 20212:54 pmRNSBlock Listing Application
3rd Feb 20214:52 pmRNSDirector/PDMR Shareholding
3rd Feb 20214:30 pmRNSTotal Voting Rights
26th Jan 20217:00 amRNSTrading Statement and Board update
25th Jan 20217:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.